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Candida albicans is an opportunistic pathogen that can cause
superficial, localized, and/or systemic infection (4). Superficial
and localized breast yeast infections (mammary candidosis) in
lactating women have been reported (1, 2). The diagnosis and
management of candidosis in the breastfeeding mother and
infant are challenging (5). Mammary candidosis is most often
presumptively diagnosed by signs or symptoms such as burning
or shooting pain in the breast during and after feedings and
persistently sore or cracked nipples that do not heal (11). In a
recent survey of 312 physicians in the Academy of Breastfeeding Medicine, 95% of family practitioners and 87% of obstetricians/gynecologists did not use laboratory tests to diagnose
mammary candidosis (5). However, diagnosis of mammary
candidosis based on symptoms alone may be erroneous, as it
has been shown that breast pain is frequently associated with
Staphylococcus aureus infection among breastfeeding women
(1, 12). On the other hand, laboratory culturing of human milk
for mammary candidosis is not well defined. Constituents of
milk (9), such as lactoferrin (10), may interfere with recovery
of Candida by culture. Iron-free human lactoferrin kills C.
albicans in a dose-dependent manner (13), whereas iron-saturated lactoferrin does not inhibit C. albicans growth (7).
Andersson et al. found that dilute, skim human milk (diluted
with RPMI 1640 medium) had fungistatic effects on C. albicans
that were reversed by the addition of iron (3). Therefore, we
studied the effects of lactoferrin, with and without added iron,
on the growth of C. albicans in undiluted whole human milk.
The objectives of this study were (i) to determine how various concentrations of lactoferrin in whole human milk affect
the growth of C. albicans and (ii) to quantitate the effect of
added iron in cultural recovery of C. albicans from human milk
containing lactoferrin. The ultimate goal was to develop a
culture technique that minimizes the likelihood of false-negative cultures.
Lactoferrin-free human milk was used as the culture medium. Lactoferrin was removed by treatment with heparin-

Sepharose (6). Lactoferrin purchased from Sigma-Aldrich (St.
Louis, Mo.) was then added to the milk to obtain three concentrations: 0.1, 1.0, and 3.0 mg per ml. Lactoferrin-free milk
and phosphate-buffered saline (PBS) served as control media.
C. albicans EK2001 isolated from human milk and maintained
on Sabouraud’s dextrose agar (SDA) was used as the inoculum. The organism was grown on SDA for 24 h at 37°C. Cells
were examined with a microscope to verify cell growth and
blastospore phase and then counted in a hemacytometer. Cells
were inoculated into milk containing or lacking lactoferrin and
PBS to provide 10, 100, or 1,000 cells per ml in duplicate
samples and then incubated for 24 h at 37°C to verify cell
growth. After incubation for 24 h, iron (300 g/ml as ferrous
sulfate) was added to one set of samples, containing 0 to 3.0 mg
of lactoferrin/ml. Another set of samples had no added iron.
All samples were incubated at 37°C. Cell concentrations were
determined with a hemacytometer at 24-h intervals. To verify
the cell counts, samples were also cultured on SDA and the
number of CFU was counted at 24-h intervals. The entire
procedure was completed in duplicate, and the cell counts and
CFU counts were averaged. The coefficient of variation in cell
counts for duplicate samples was ⬍10% in all cases and ⬍5%
in 85% of the cases. Inhibition of growth by lactoferrin was
determined by comparing the number of C. albicans cells (or
CFU per milliliter) after 96 h of incubation to the values in the
control milk with no lactoferrin and no added iron. Analysis of
variance was used to analyze the main effects of (i) inoculum
size, (ii) lactoferrin concentration, and (iii) no added iron or
added iron.
In a parallel study to determine the prevalence of C. albicans
among lactating women, samples of freshly expressed milk with
and without added ferrous sulfate (300 g of iron/ml) were
cultured on SDA to determine the influence of added iron on
recovery of Candida species.
Because the correlation between cell counts and CFU was
very high (r ⫽ 0.96), we report herein only the results for the
cell counts. Growth of C. albicans in lactoferrin-free human
milk was significantly associated with the size of the inoculum
(Table 1). The slope of the ascent for the number of cells per
milliliter declined after 48 h except for the 103-cell inoculum.
The effect of added lactoferrin is indicated in Table 1 (ab-
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Procedures for diagnosis of mammary candidosis, including laboratory confirmation, are not well defined.
Lactoferrin present in human milk can inhibit growth of Candida albicans, thereby limiting the ability to detect
yeast infections. The inhibitory effect of various lactoferrin concentrations on the growth of C. albicans in whole
human milk was studied. The addition of iron to the milk led to a two- to threefold increase in cell counts when
milk contained 3.0 mg of lactoferrin/ml and markedly reduced the likelihood of false-negative culture results.
This method may provide the necessary objective support needed for diagnosis of mammary candidosis.
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TABLE 1. Cell concentrations of C. albicans in human milka
Cell count (103)
Added iron (300 g/ml)

No added iron

Inoculum and growth medium
24 h

48 h

72 h

96 h

24 h

48 h

72 h

96 h

0.004
400
375
100
75

0
2,490
1,780
1,080
380

0
3,075
2,200
1,175
500

0
3,143
2,240
1,200
510

0.005
400
375
100
75

0
3,600
3,225
2,375
1,275

0
3,665
3,380
2,418
1,308

0
3,767
3,538
2,474
1,345

100 cells/ml
PBS
Lactoferrin-free milk
Milk ⫹ 0.1 mg of lactoferrin/ml
Milk ⫹ 1.0 mg of lactoferrin/ml
Milk ⫹ 3.0 mg of lactoferrin/ml

0.05
625
525
250
200

0.02
6,421
4,132
1,776
1,562

0
7,525
4,800
2,400
1,775

0
7,765
4,886
2,533
1,807

0.07
625
525
250
200

0.03
8,850
7,900
5,375
2,975

0
9,093
8,142
5,570
3,029

0
9,353
8,246
5,717
3,113

1,000 cells/ml
PBS
Lactoferrin-free milk
Milk ⫹ 0.1 mg of lactoferrin/ml
Milk ⫹ 1.0 mg of lactoferrin/ml
Milk ⫹ 3.0 mg of lactoferrin/ml

0.64
800
750
725
425

0.31
11,991
7,056
3,977
2,386

0
14,275
8,400
5,375
2,775

0
17,986
8,551
5,577
2,924

0.72
800
750
725
425

0.34
56,980
30,150
20,250
6,975

0.12
67,250
36,750
27,500
7,155

0
80,020
38,672
28,847
7,357

a
The main effects of inoculum size (P ⬍ 0.001), lactoferrin concentration (P ⬍ 0.001), and addition of iron (P ⬍ 0.001) were all highly significant. In addition, the
interaction of iron with size of inoculum was significant (P ⫽ 0.01): the effect of iron on growth of C. albicans was greatest when the inoculum contained 1,000 cells/ml.

solute cell counts) and Fig. 1, 2, and 3 (percent of lactoferrinfree control). At all three levels of inoculation and at each time
of observation, the replication of C. albicans was inhibited by
lactoferrin. The inhibition of replication was significantly related to the concentration of lactoferrin (P ⫽ 0.001). Milk
samples containing 1.0 mg of lactoferrin/ml yielded less than
50% of the growth produced in the absence of lactoferrin. At
3.0 mg/ml, lactoferrin also had a notable effect on the morphology of C. albicans; blastospores were smaller (1.5 to 2.0

m compared to 4 to 5 m in the lactoferrin-free milk). The
addition of iron significantly increased growth of C. albicans
(P ⫽ 0.001) in the absence or presence of lactoferrin. This
stimulation of growth by the presence of iron was greatest in
lactoferrin-free milk inoculated with 103 cells/ml but was also
evident with the smaller inocula. The addition of iron (300 g/
ml) restored growth to at least 100% of that observed in the
lactoferrin-free controls (without added iron) at the 0.1-mg/ml
lactoferrin concentration, to at least 75% of the control value

FIG. 1. Effect of added iron (300 g/ml) on growth of C. albicans in whole human milk with added lactoferrin at an inoculum size of 10 cells/ml.
Cells were incubated for a total of 96 h at 37°C. Cell counts are shown as a percentage of the lactoferrin-free control with no added iron. Lactoferrin
significantly inhibited the growth of C. albicans (P ⬍ 0.01), and adding iron reversed most of the inhibition (P ⬍ 0.001). Stippled bars, no added
iron; hatched bars, added iron.
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10 cells/ml
PBS
Lactoferrin-free milk
Milk ⫹ 0.1 mg of lactoferrin/ml
Milk ⫹ 1.0 mg of lactoferrin/ml
Milk ⫹ 3.0 mg of lactoferrin/ml
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at the 1.0-mg/ml concentration, and to at least 40% of the
control value at the 3.0-mg/ml concentration.
When the rates of recovery of C. albicans directly from
samples of milk with and without added iron in the parallel
prevalence study of 100 women were compared, the addition of
iron to the milk prior to inoculation yielded positive cultures in
28 samples, compared with 5 positive (23 negative) without the
addition of iron.
The present findings provide evidence that the size of the
inoculum (concentration of C. albicans cells) influences the
rate of growth of this yeast in whole human milk in vitro, that

lactoferrin can inhibit the growth of C. albicans in human milk,
and that this inhibition can be reversed by the addition of
ferrous iron.
The concentration of lactoferrin is 3.1 mg/ml in transitional
milk (6 to 14 days postpartum), 2.0 mg/ml in early mature milk
(15 to 28 days postpartum), and 0.5 to 1.5 mg/ml at 30 days
postpartum (7, 8). At all these stages, particularly early postpartum, lactoferrin is present at concentrations which were
significantly inhibitory to C. albicans in vitro.
The addition of iron (ferrous) countered the inhibitory effect
of lactoferrin. For example, 300 g of iron/ml (a 5.35 M solu-

FIG. 3. Effect of added iron (300 g/ml) on growth of C. albicans in whole human milk with added lactoferrin at an inoculum size of 1,000
cells/ml. Cells were incubated for a total of 96 h at 37°C. Cell counts are shown as a percentage of the lactoferrin-free control with no added iron.
Lactoferrin significantly inhibited the growth of C. albicans (P ⬍ 0.001), and adding iron reversed most of the inhibition (P ⬍ 0.001). Stippled bars,
no added iron; hatched bars, added iron.
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FIG. 2. Effect of added iron (300 g/ml) on growth of C. albicans in whole human milk with added lactoferrin at an inoculum size of 100
cells/ml. Cells were incubated for a total of 96 h at 37°C. Cell counts are shown as a percentage of the lactoferrin-free control with no added iron.
Lactoferrin significantly inhibited the growth of C. albicans (P ⬍ 0.01), and adding iron reversed most of the inhibition (P ⬍ 0.001). Stippled bars,
no added iron; hatched bars, added iron.
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tion) led to approximately a two- to threefold increase in cell
counts in the presence of 3.0 mg of lactoferrin/ml (a 38.4 M
solution).
The addition of iron demonstrably increased the rate of
recovery of C. albicans from whole human milk. Our results
suggest that the addition of iron to whole human milk samples
reduces the likelihood of a false-negative result in laboratory
tests. Additional clinical trials are needed to determine the
extent to which this method of culturing milk will be applicable
in enhancing detection of C. albicans in human milk.
This project was funded by Supplemental Hatch Funds from the
University of California, Davis.
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